3 hrs ago | Connecticut Post
Property taken with or without charges
Across the United States,seizures are carried out by agents who work for many diverse federal law enforcement agencies - including the DEA, U.S. Customs and Border Protection, the U.S. Postal Service, the IRS, the FDA, the FBI and the Secret Service among others.
7 hrs ago | Log Cabin Democrat
Griffin joins Exchange Capital
Kevin Griffin has joined Exchange Capital Corporation as Executive Vice President.
11 hrs ago | Sys-Con Media
In the Know, Smart Investing in PFE, SIRI, INTC and P
Don't waste time trying to figure it out for yourself; tip the scales in your favor and add our experience to your team.
22 hrs ago | Seeking Alpha
Pfizer Will Reward Shareholders With Zoetis Spin-Off
At the beginning of 2013, I selected pharmaceutical giant Pfizer as one of my top ten stock picks for the year.
Asset forfeiture both an effective tool, civil-liberties nightmare
Corporations, rather than mafia bosses, have forked over what U.S. Department of Justice officials have described as some of the largest cases in U.S. history, based on data and documents from the fiscal year 2010-2012. In this photo, Stanford Financial Group's assets are pictured.
World Ion Channel Modulating Drugs Marke ...
The global ion channel modulators market is forecast to reach a value of USD 21.4bn by end-2018, driven largely by deeper understanding of channelopathies and ongoing advances in electrophysiology, particularly automated electrophysiology.
Drug Giants Such as Bayer AG, Pfizer Inc., and Roche Accused of Shady Soviet-Era Drug Trials
Drug Giants Such as Bayer AG , Pfizer Inc. , and Roche Accused of Shady Soviet-Era Drug Trials Staying up-to-date has never been simpler.
Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
Lpath, Inc. , the industry leader in bioactive lipid-targeted therapeutics,has initiated dosing in a Phase 2a single-arm trial where ASONEP is being investigated as a treatment for renal cell carcinoma in subjects that have failed the standard of care treatment with FDA-approved agents that block VEGF signaling /sunitinib maleate) and the mTOR ... (more)
Pfizer Has Potential To Grow Despite Decreasing Sales
Pfizer is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in prescription drugs and healthcare products.
Wall Street Fundamentals Releases New In-Depth Stock Reports on BAC,...
May 23rd, 2013 - Markets received an early boost Wednesday after comments from Federal Reserve Chairman Ben Bernanke signaled that the central bank was not ready to ease up on economic stimulus.
Pfizer Stock Rating Reaffirmed by Independent Research GmbH
's stock had its "hold" rating reaffirmed by research analysts at Independent Research GmbH in a report released on Thursday, Stock Ratings Network reports.
Another Look At Marketing Vs. R&D In Pharma
FiercePharma has some good figures to back up my posts the other day on R&D spending versus marketing .
Pfizer Inc. to Stay in Madison, 475 Jobs Saved
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Two months after Pfizer announced the sale of its property at 5 Giralda Farms, the company says it's only moving across the corporate campus.
MannKind's Afrezza And The Oramed Threat
My last article concerning MannKind Corp. was a discussion of how its Afrezza will succeed where Pfizer's Exubera failed.
Ready to Profit? Start Here Now With BAC, PFE, GE and F
Don't waste time trying to figure it out for yourself; tip the scales in your favor and add our experience to your team.
Pfizer takes its shot at a vaccine for evasive superbug
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year pneumonia and meningitis vaccine Prevnar 13 for Pfizer.
Deals of the day -- mergers and acquisitions
** Oslo-listed oil services company Archer has agreed to sell its North American Rental and Tubular division to an affiliate of the Clearlake Capital Group for $244 million, it said on Wednesday.
Pfizer halts study of non-Hodgkin lymphoma drug
Our eNewspaper network was founded in 2002 to provide stand-alone digital news sites tailored for the most searched-for locations for news.
Rite Aid Corporation (RAD): This Company Is Making a Killing on the Patent Cliff
If you have been following the pharmaceutical industry lately, then you're probably no stranger to the "Patent Cliff" phenomenon that the industry is facing.
Pfizer plans offering to pare Zoetis stake
Drugmaker Pfizer Inc. plans to try to sell its controlling stake in its former animal health business, Zoetis Inc., through a voluntary stock exchange with Pfizer shareholders.